Drug Profile
LG 1411
Latest Information Update: 04 Aug 1998
Price :
$50
*
At a glance
- Originator Lifegroup
- Class Antihyperglycaemics
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 04 Aug 1998 No-Development-Reported for Type-2 diabetes mellitus in Italy (Unknown route)
- 09 Oct 1996 Preclinical development for Type-2 diabetes mellitus in Italy (Unknown route)